sodium glutamate has been researched along with Precancerous Conditions in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, A; Hata, K; Hirose, Y; Kubota, M; Kuno, T; Moriwaki, H; Shimizu, M; Tanaka, T | 1 |
| Mori, T; Nagasawa, H; Namiki, H; Niki, K; Noguchi, Y | 1 |
2 other study(ies) available for sodium glutamate and Precancerous Conditions
| Article | Year |
|---|---|
Monosodium glutamate-induced diabetic mice are susceptible to azoxymethane-induced colon tumorigenesis.
Topics: Animals; Azoxymethane; Colonic Neoplasms; Diabetes Mellitus, Experimental; Disease Models, Animal; Disease Susceptibility; Hypercholesterolemia; Hyperglycemia; Hyperinsulinism; Insulin-Like Growth Factor I; Male; Mice; Mice, Inbred ICR; Precancerous Conditions; Receptor, IGF Type 1; RNA, Messenger; Sodium Glutamate | 2012 |
Suppression of normal and preneoplastic mammary growth and uterine adenomyosis with reduced growth hormone level in SHN mice given monosodium glutamate neonatally.
Topics: Animals; Animals, Newborn; Body Weight; Endocrine Glands; Endometriosis; Estrus; Female; Glutamates; Growth Hormone; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Precancerous Conditions; Prolactin; Sodium Glutamate; Uterine Neoplasms | 1985 |